Shanghai Hile Bio-Technology Co., Ltd., commonly referred to as Hile Bio, is a leading player in the biotechnology sector, headquartered in Shanghai, China. Established in 2004, the company has made significant strides in the development of innovative biopharmaceuticals and health products, focusing on areas such as enzyme production and microbial fermentation. Hile Bio's core offerings include high-quality enzymes and probiotics, distinguished by their advanced formulation and efficacy. The company has garnered a strong market position, recognised for its commitment to research and development, which has led to numerous industry accolades. With a robust operational presence across Asia and beyond, Hile Bio continues to drive advancements in biotechnology, contributing to health and wellness on a global scale.
How does Shanghai Hile Bio-Technology Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Shanghai Hile Bio-Technology Co., Ltd.'s score of 22 is lower than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Shanghai Hile Bio-Technology Co., Ltd., headquartered in China, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi). As there are no emissions data or reduction initiatives available, it is unclear how Shanghai Hile Bio-Technology Co., Ltd. is addressing its carbon footprint or contributing to climate action within its industry. The lack of reported data may suggest an opportunity for the company to enhance its sustainability practices and align with global climate commitments.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Shanghai Hile Bio-Technology Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

